Abstract
BackgroundCardiovascular (CV) morbidity and mortality are increased in patients with arthritides, including ankylosing spondylitis (AS). Biologics may influence vascular function and lipids in AS, however a lot more information has...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
